These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 26032400)
1. Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products. McRobert EA; Bach LA Nephrology (Carlton); 2016 Jan; 21(1):13-20. PubMed ID: 26032400 [TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products inhibit adhesion ability of differentiated podocytes in a neuropilin-1-dependent manner. Bondeva T; Wojciech S; Wolf G Am J Physiol Renal Physiol; 2011 Oct; 301(4):F852-70. PubMed ID: 21734098 [TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes. Rüster C; Bondeva T; Franke S; Förster M; Wolf G Nephrol Dial Transplant; 2008 Jul; 23(7):2179-91. PubMed ID: 18344241 [TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end-products suppress neuropilin-1 expression in podocytes. Bondeva T; Rüster C; Franke S; Hammerschmid E; Klagsbrun M; Cohen CD; Wolf G Kidney Int; 2009 Mar; 75(6):605-16. PubMed ID: 19037249 [TBL] [Abstract][Full Text] [Related]
5. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway. Kim DY; Kang MK; Lee EJ; Kim YH; Oh H; Kang YH Mol Nutr Food Res; 2018 Oct; 62(19):e1800302. PubMed ID: 29987888 [TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB. Zhao X; Chen Y; Tan X; Zhang L; Zhang H; Li Z; Liu S; Li R; Lin T; Liao R; Zhang Q; Dong W; Shi W; Liang X J Pathol; 2018 Jun; 245(2):235-248. PubMed ID: 29570219 [TBL] [Abstract][Full Text] [Related]
7. Uptake of advanced glycation end products by proximal tubule epithelial cells via macropinocytosis. Gallicchio MA; Bach LA Biochim Biophys Acta; 2013 Dec; 1833(12):2922-2932. PubMed ID: 23747564 [TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner. Gallicchio MA; McRobert EA; Tikoo A; Cooper ME; Bach LA J Am Soc Nephrol; 2006 Feb; 17(2):414-21. PubMed ID: 16371434 [TBL] [Abstract][Full Text] [Related]
9. Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signalling. Ha TS; Hong EJ; Han GD Diabetes Metab Res Rev; 2015 Jan; 31(1):50-60. PubMed ID: 24846128 [TBL] [Abstract][Full Text] [Related]
10. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor. Chuang PY; Yu Q; Fang W; Uribarri J; He JC Kidney Int; 2007 Oct; 72(8):965-76. PubMed ID: 17667983 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin protects podocytes from damage by advanced glycation end-products. Ruester C; Franke S; Bondeva T; Wolf G Nephron Exp Nephrol; 2011; 117(1):e21-30. PubMed ID: 20689331 [TBL] [Abstract][Full Text] [Related]
12. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy. Zhang M; Liu M; Xiong M; Gong J; Tan X J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431 [TBL] [Abstract][Full Text] [Related]
13. Ezrin is down-regulated in diabetic kidney glomeruli and regulates actin reorganization and glucose uptake via GLUT1 in cultured podocytes. Wasik AA; Koskelainen S; Hyvönen ME; Musante L; Lehtonen E; Koskenniemi K; Tienari J; Vaheri A; Kerjaschki D; Szalay C; Révész C; Varmanen P; Nyman TA; Hamar P; Holthöfer H; Lehtonen S Am J Pathol; 2014 Jun; 184(6):1727-39. PubMed ID: 24726496 [TBL] [Abstract][Full Text] [Related]
14. Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression. Liebisch M; Bondeva T; Franke S; Daniel C; Amann K; Wolf G Kidney Int; 2014 Jul; 86(1):103-17. PubMed ID: 24476693 [TBL] [Abstract][Full Text] [Related]
15. High glucose induces Nox4 expression and podocyte apoptosis through the Smad3/ezrin/PKA pathway. Guo W; Gao H; Pan W; Yu P; Che G Biol Open; 2021 May; 10(5):. PubMed ID: 33046439 [TBL] [Abstract][Full Text] [Related]
16. Ginseng Total Saponin Attenuates Podocyte Apoptosis Induced by Diabetic Conditions Through the Recovery of CD2-Associated Protein. Ha TS; Ha DS J Med Food; 2019 Feb; 22(2):170-177. PubMed ID: 30601089 [TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end-products induce calpain-mediated degradation of ezrin. McRobert EA; Young AN; Bach LA FEBS J; 2012 Sep; 279(17):3240-50. PubMed ID: 22805611 [TBL] [Abstract][Full Text] [Related]
18. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy. Jung E; Kim J; Ho Kim S; Kim S; Cho MH Eur J Pharmacol; 2015 Aug; 761():116-24. PubMed ID: 25977232 [TBL] [Abstract][Full Text] [Related]
19. Role of CD2-associated protein in albumin overload-induced apoptosis in podocytes. He FF; Zhang C; Chen S; Deng BQ; Wang H; Shao N; Tian XJ; Fang Z; Sun XF; Liu JS; Zhu ZH; Meng XF Cell Biol Int; 2011 Aug; 35(8):827-34. PubMed ID: 21166652 [TBL] [Abstract][Full Text] [Related]
20. The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications. McRobert EA; Gallicchio M; Jerums G; Cooper ME; Bach LA J Biol Chem; 2003 Jul; 278(28):25783-9. PubMed ID: 12734202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]